Stocktoria

Veradermics, Inc MANE

NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2026-02-04

Veradermics, Inc statistics & valuation

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-45.9%-47.7%
Return on equity57.8%54.6%
Current ratio16.6611.77

Source: SEC EDGAR filings · CIK 0001827635 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.